Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v8-FR
Language English French
Date Updated 2017-07-07 2017-06-21
Drug Identification Number 02240836 02240836
Brand name ADVAIR 250 DISKUS ADVAIR 250 DISKUS
Common or Proper name Fluticasone propionate and salmeterol inhalation powder Fluticasone propionate and salmeterol inhalation powder
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients SALMETEROL FLUTICASONE PROPIONATE SALMETEROL FLUTICASONE PROPIONATE
Strength(s) 50MCG 250MCG 50MCG 250MCG
Dosage form(s) POWDER POWDER
Route of administration INHALATION INHALATION
Packaging size 1x28 doses 1x28 doses
ATC code R03AK R03AK
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-31 2017-05-31
Estimated end date 2017-07-11 2017-07-07
Actual end date 2017-07-06
Shortage status Resolved Actual shortage
Company comments ADVAIR DISKUS 250: 60 dose presentation is available. ADVAIR DISKUS 250: 60 dose presentation is available.
Health Canada comments